You just read:

Therabron Therapeutics Reaches 50 Percent Enrollment in Phase 2 Clinical Trial for Lead Pediatric Respiratory Critical Care Program

News provided by

Therabron Therapeutics, Inc.

Jul 21, 2015, 09:17 ET